A real world single-center, retrospective study assessing the efficacy of and the patterns of available, outpatient COVID-19 therapies in solid organ transplant recipients during the Omicron surge
Latest Information Update: 26 May 2022
At a glance
- Drugs Molnupiravir (Primary) ; Nirmatrelvir+ritonavir (Primary) ; Sotrovimab (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
Most Recent Events
- 26 May 2022 New trial record
- 18 May 2022 Results published in the American Journal of Transplantation